Michael Mee
Managing Director at Pre
Montreal, Quebec
Overview
Work Experience
Managing Director
2023 - Current
Principal
2019
Amplitude Ventures is a capital catalyst for highly innovative companies at the point of value acceleration. We work with Canada's most promising healthcare companies that share our vision of bringing groundbreaking technologies to patients. Amplitude is focused on building world-class Canadian companies in precision medicine and next-generation medical devices.
Co-Founder
2019
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells and gene therapies as medicines. This new class of medicines is based on recent scientific advances that make it possible to treat a broad array of diseases. We are a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that will change how we approach treating disease.
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Raised $865,000,000.00 from Bezos Expeditions, CPP Investments, ARCH Venture Partners, F-Prime Capital, Google Ventures, Alaska Permanent Fund, Altitude Life Science Ventures, Omega Funds, Flagship Pioneering and Baillie Gifford.
Senior Associate
2017 - 2019
Fueled by curiosity and a quest for new sources of future value, Flagship conceives, creates, resources and grows first-in-category life sciences companies. Our unique, systematic, hypothesis-driven innovation process empowers us simultaneously to explore the world’s biggest problems and to conceive disruptive scientific solutions. Our ventures deliver breakthrough medicines, maximize the potential of new agricultural practices, and power the world with innovative resources. We call this Pioneering. Since our founding in 2000, we have originated and fostered the development of more than 75 scientific ventures resulting in $19 billion in aggregate value, 500+ issued patents, and more than 50 clinical trials for novel therapeutic agents. Innovation is our currency. Our creativity, optimism, boundless energy, and curiosity fuel Flagship’s success. We pioneer scientific ventures for life.
Associate
2015 - 2017
VentureLabs Fellow
2015 - 2015
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Co-Founder and Head of Innovation
2016 - 2018
Cobalt Biomedicine is developing a new class of therapeutics based on the ability to deliver into cells essentially any biological payload, ranging from defined molecular polymers to cellular organelles, with unprecedented cell specificity. This approach enables direct and highly targeted intervention inside the cell opening up vast opportunities across diverse therapeutic areas, with the potential to transiently or permanently correct for defects at the root of diseases. Cobalt Biomedicine was founded by Flagship Pioneering.
Scientific Strategy and Operations
2016 - 2016
Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maintain health. Since its founding in 2015 by Flagship Pioneering, Kaleido has advanced candidate products into clinical studies across programs in rare genetic diseases, oncology and infectious disease, and has generated more than 3,000 days of human clinical data. The Company is also creating consumer products that optimize the microbiome's natural roles in promoting health.
Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.
Raised $230,900,000.00 from Invus, Abu Dhabi Investment Authority, Rock Springs Capital, Fidelity and Flagship Pioneering.
CoFounder
2014 - 2015
Doctoral Student
2010 - 2015